TLR2 and myeloid sarcoma: Based on studies relating TLR2 to the inhibition of remyelination [13–15] and the potential for therapeutic intervention in EAE and MS via TLR2 tolerance induction [10, 17], the goal of the present study was to test the role of TLR2 and TLR2 tolerance induction in the process of CNS remyelination.